We often remind clients that the False Claims Act (FCA) — though written during the Civil War — is continually shaped by modern court decisions. Over the decades, several U.S. Supreme Court rulings have refined how the FCA is interpreted, influencing everything from what counts as a “false claim” to how whistleblowers can recover damages. […]
Notable Supreme Court Rulings on FCA Interpretation Read More »
The Civil Monetary Penalties Law (CMPL) is a critical but sometimes overlooked companion to the False Claims Act. While the FCA focuses on fraud, the CMPL targets a wide range of misconduct that wastes federal healthcare funds. When the conduct at issue concerns federal healthcare programs such as Medicare, the CPML is generally administered by
Civil Monetary Penalties Law (CMPL) Read More »
The False Claims Act (FCA) is the single most powerful tool for combating fraud against the U.S. government. It’s also the foundation for nearly every major healthcare fraud case we see today. Originally passed during the Civil War in 1863, the FCA was designed to stop suppliers from defrauding the Union Army. It has since
False Claims Act (31 U.S.C. §§ 3729–3733) Read More »
In 2012, GlaxoSmithKline (GSK) agreed to pay $3 billion in what was then the largest healthcare fraud settlement in U.S. history. At Barrett Johnston, we highlight this case because it shows the incredible scale of misconduct that whistleblowers and federal investigators can uncover when they work together. The case centered on allegations that GSK engaged
GlaxoSmithKline $3 Billion Settlement (2012) Read More »
